The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Open accessAbstract
The Transforming Growth Factor-beta (TGF-β) family plays relevant roles in the regulation of different cellular processes that are essential for tissue and organ homeostasis. In the case of the liver, TGF-β signaling participates in different stages of disease progression, from initial liver injury toward fibrosis, cirrhosis and cancer. When a chronic injury takes place, mobilization of lymphocytes and other inflammatory cells occur, thus setting the stage for persistence of an inflammatory response. Macrophages produce profibrotic mediators, among them, TGF-β, which is responsible for activation -transdifferentiation- of quiescent hepatic stellate cells (HSC) to a myofibroblast (MFB) phenotype. MFBs are the principal source of extracellular matrix protein (ECM) accumulation and prominent mediators of fibrogenesis. TGF-β also mediates an epithelial-mesenchymal transition (EMT) process in hepatocytes that may contribute, directly or indirectly, to increase the MFB population. In hepatocarcinogenesis, TGF-β plays a dual role, behaving as a suppressor factor at early stages, but contributing to later tumor progression, once cells escape from its cytostatic effects. As part of its potential pro-tumorigenic actions, TGF-β induces EMT in liver tumor cells, which increases its pro-migratory and invasive potential. In parallel, TGF-β also induces changes in tumor cell plasticity, conferring properties of a migratory tumor initiating cell (TIC). The main aim of this review is to shed light about the pleiotropic actions of TGF-β that explain its effects on the different liver cell populations. The cross-talk with other signaling pathways that contribute to TGF-β effects, in particular the Epidermal Growth Factor Receptor (EGFR), will be presented. Finally, we will discuss the rationale for targeting the TGF-β pathway in liver pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“Macrophages are classify into M1, also known as classical or pro-inflammatory; and M2, also known as alternative or anti-inflammatory macrophages (51, 52).”
BackgroundOncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 1×
“Even more, EMT is classified into different subclasses related with the biological context (78): Type 1 EMT is involved in development stages; type 2 EMT concerns regenerative process and organ fibrosis; and type 3 EMT is related with metastatic process.”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Signaling mechanisms of the epithelial-mesenchymal transition
Gonzalez, D. M., & Medici, D. (2014) · Science Signaling · doi:10.1126/scisignal.2005189 · Cited by 1,721
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Inflammation and wound healing: the role of the macrophage
Koh, T. J., & DiPietro, L. A. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001943 · Cited by 1,667
Plasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551 · cited 1×
“Treg cells -Foxp3-positive cellsare involved in immune homeostasis, peripheral tolerance and prevention of autoimmunity (210, 211).”
BackgroundTumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Hepatocellular carcinoma: clinical frontiers and perspectives
Bruix, J., Gores, G. J., & Mazzaferro, V. (2014) · Gut · doi:10.1136/gutjnl-2013-306627 · Cited by 1,364
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Hepatocellular carcinoma: a review
Balogh, J., Victor, D., Asham, E. H., Burroughs, S. G., Boktour, M., Saharia, A., Li, X., Ghobrial, M., & Monsour, H. (2016) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s61146 · Cited by 1,185
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Paik, J.-H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.029 · Cited by 1,032
TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
Yang, L., Pang, Y., & Moses, H. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.002 · Cited by 1,023
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., & Arteaga, C. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005912200 · Cited by 992
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
Nieto, M. A. (2013) · Science · doi:10.1126/science.1234850 · Cited by 967
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Willis, B. C., Liebler, J. M., Luby-Phelps, K., Nicholson, A. G., Crandall, E. D., du Bois, R. M., & Borok, Z. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62351-6 · Cited by 951
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
Kuang, D.-M., Zhao, Q., Peng, C., Xu, J., Zhang, J.-P., Wu, C., & Zheng, L. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 903
Henderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., Pennathur, S., Martinez, F. J., & Thannickal, V. J. (2009) · Nature Medicine · doi:10.1038/nm.2005 · Cited by 852
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., & Kalluri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700194200 · Cited by 839
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
TGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800
Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., & Sorescu, D. (2005) · Circulation Research · doi:10.1161/01.res.0000187457.24338.3d · Cited by 786
Karlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Hernandez–Gea, V., Toffanin, S., Friedman, S. L., & Llovet, J. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.002 · Cited by 722
Hepatic stellate cells in liver development, regeneration, and cancer
Yin, C., Evason, K. J., Asahina, K., & Stainier, D. Y. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66369 · Cited by 719
TGF-β in progression of liver disease
Dooley, S., & ten Dijke, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1246-y · Cited by 718
Signaling Receptors for TGF-β Family Members
Heldin, C.-H., & Moustakas, A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022053 · Cited by 711
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Giannelli, G., Koudelkova, P., Dituri, F., & Mikulits, W. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.007 · Cited by 615
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613
Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
TGF‐β signalling and liver disease
Fabregat, I., Moreno‐Càceres, J., Sánchez, A., Dooley, S., Dewidar, B., Giannelli, G., ten Dijke, P., & the IT‐LIVER Consortium (2016) · The FEBS Journal · doi:10.1111/febs.13665 · Cited by 600
Self-citationEvolving therapies for liver fibrosis
Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 595
Zhang, F., Wang, H., Wang, X., Jiang, G., Liu, H., Zhang, G., Wang, H., Fang, R., Bu, X., Cai, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10561 · Cited by 580
Lamouille, S., & Derynck, R. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611146 · Cited by 572
Cellular and Molecular Mechanisms of Liver Injury
Malhi, H., & Gores, G. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.002 · Cited by 560
Origin of myofibroblasts in the fibrotic liver in mice
Iwaisako, K., Jiang, C., Zhang, M., Cong, M., Moore-Morris, T. J., Park, T. J., Liu, X., Xu, J., Wang, P., Paik, Y.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400062111 · Cited by 535
Khalil, N., Bereznay, O., Sporn, M., & Greenberg, A. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.727 · Cited by 505
Regulation of EMT by TGFβ in cancer
Heldin, C.-H., Vanlandewijck, M., & Moustakas, A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.037 · Cited by 505
The Bone Marrow Functionally Contributes to Liver Fibrosis
Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F., Bou–Gharios, G., Jeffery, R., Iredale, J. P., & Forbes, S. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.036 · Cited by 483
Macrophages During the Fibrotic Process: M2 as Friend and Foe
Braga, T. T., Agudelo, J. S. H., & Camara, N. O. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00602 · Cited by 464
Zeisberg, M., & Kalluri, R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00328.2012 · Cited by 462
Fan, Q.-M., Jing, Y.-Y., Yu, G.-F., Kou, X.-R., Ye, F., Gao, L., Li, R., Zhao, Q.-D., Yang, Y., Lu, Z.-H., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.008 · Cited by 458
Fibrosis-dependent mechanisms of hepatocarcinogenesis
Zhang, D. Y., & Friedman, S. L. (2012) · Hepatology · doi:10.1002/hep.25670 · Cited by 444
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Barnes, J. L., & Gorin, Y. (2011) · Kidney International · doi:10.1038/ki.2010.516 · Cited by 432
TGF-β signalling and its role in cancer progression and metastasis
Drabsch, Y., & ten Dijke, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9375-7 · Cited by 428
Gene Expression Profiles During Hepatic Stellate Cell Activation in Culture and In Vivo
De Minicis, S., Seki, E., Uchinami, H., Kluwe, J., Zhang, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.033 · Cited by 426
Maher, J. J., & McGuire, R. F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114886 · Cited by 423
TGFβ signaling plays a critical role in promoting alternative macrophage activation
Gong, D., Shi, W., Yi, S.-J., Chen, H., Groffen, J., & Heisterkamp, N. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-31 · Cited by 420
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update
Elpek, G. Ö. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7260 · Cited by 382
The cholangiopathies: Disorders of biliary epithelia
Lazaridis, K. N., Strazzabosco, M., & LaRusso, N. F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.006 · Cited by 372
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Peng, X., Gulati, M., Homer, R. J., Russell, T., van Rooijen, N., et al. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.10.013 · Cited by 362 · cited 1×
“In other fibrotic animal models, such as lung fibrosis, TGF-β could modulate M2 responses (57); and in kidney, TGF-β/Smad3-dependt pathway could transdifferentiate M2-macrophages to myofibroblast favoring kidney fibrosis (58).”
BackgroundKaimori, A., Potter, J., Kaimori, J.-Y., Wang, C., Mezey, E., & Koteish, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700998200 · Cited by 355
TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
Caja, L., Dituri, F., Mancarella, S., Caballero-Diaz, D., Moustakas, A., Giannelli, G., & Fabregat, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051294 · Cited by 351
Self-citationTGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
Wang, B., Hsu, S. H., Majumder, S., Kutay, H., Huang, W., Jacob, S. T., & Ghoshal, K. (2010) · Oncogene · doi:10.1038/onc.2009.468 · Cited by 348
Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336
Lau, E. Y. T., Lo, J., Cheng, B. Y. L., Ma, M. K. F., Lee, J. M. F., Ng, J. K. Y., Chai, S., Lin, C. H., Tsang, S. Y., Ma, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.019 · Cited by 334
Coulouarn, C., Factor, V. M., & Thorgeirsson, S. S. (2008) · Hepatology · doi:10.1002/hep.22283 · Cited by 332
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Li, T., Yang, Y., Hua, X., Wang, G., Liu, W., Jia, C., Tai, Y., Zhang, Q., & Chen, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.020 · Cited by 328
Metastasis: cancer cell’s escape from oxidative stress
Pani, G., Galeotti, T., & Chiarugi, P. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9225-4 · Cited by 313
Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer
Khor, T. O., Huang, M.-T., Prawan, A., Liu, Y., Hao, X., Yu, S., Cheung, W. K. L., Chan, J. Y., Reddy, B. S., Yang, C. S., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0028 · Cited by 306
Jobling, M. F., Mott, J. D., Finnegan, M. T., Jurukovski, V., Erickson, A. C., Walian, P. J., Taylor, S. E., Ledbetter, S., Lawrence, C. M., Rifkin, D. B., et al. (2006) · Radiation Research · doi:10.1667/rr0695.1 · Cited by 300
Recent advancement of molecular mechanisms of liver fibrosis
Seki, E., & Brenner, D. A. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.245 · Cited by 300
NAD(P)H Oxidase Mediates TGF-β1–Induced Activation of Kidney Myofibroblasts
Bondi, C. D., Manickam, N., Lee, D. Y., Block, K., Gorin, Y., Abboud, H. E., & Barnes, J. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009020146 · Cited by 297
TGF-β upregulates miR-181a expression to promote breast cancer metastasis
Taylor, M. A., Sossey-Alaoui, K., Thompson, C. L., Danielpour, D., & Schiemann, W. P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64946 · Cited by 288
Dooley, S., Hamzavi, J., Ciuclan, L., Godoy, P., Ilkavets, I., Ehnert, S., Ueberham, E., Gebhardt, R., Kanzler, S., Geier, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.038 · Cited by 281
Cheng, J.-T., Deng, Y.-N., Yi, H.-M., Wang, G.-Y., Fu, B.-S., Chen, W.-J., Liu, W., Tai, Y., Peng, Y.-W., & Zhang, Q. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.7 · Cited by 267
P38 Mapk Mediates Fibrogenic Signal Through Smad3 Phosphorylation in Rat Myofibroblasts
Furukawa, F., Matsuzaki, K., Mori, S., Tahashi, Y., Yoshida, K., Sugano, Y., Yamagata, H., Matsushita, M., Seki, T., Inagaki, Y., et al. (2003) · Hepatology · doi:10.1002/hep.1840380414 · Cited by 265
Ontogeny and Polarization of Macrophages in Inflammation: Blood Monocytes Versus Tissue Macrophages
Dey, A., Allen, J., & Hankey-Giblin, P. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00683 · Cited by 254
Differentiation and function of Kupffer cells
Naito, M., Hasegawa, G., Ebe, Y., & Yamamoto, T. (2004) · Medical Electron Microscopy · doi:10.1007/s00795-003-0228-x · Cited by 252
Jiang, J. X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schröder, K., Brandes, R. P., Devaraj, S., & Török, N. J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.007 · Cited by 251
Wang, S., Meng, X.-M., Ng, Y.-Y., Ma, F. Y., Zhou, S., Zhang, Y., Yang, C., Huang, X.-R., Xiao, J., Wang, Y.-Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6604 · Cited by 235
Dooley, S., Delvoux, B., Lahme, B., Mangasser-Stephan, K., & Gressner, A. M. (2000) · Hepatology · doi:10.1053/he.2000.6126 · Cited by 230
Carmona-Cuenca, I., Roncero, C., Sancho, P., Caja, L., Fausto, N., Fernández, M., & Fabregat, I. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.021 · Cited by 222
Self-citationRole of NADPH Oxidases in Liver Fibrosis
Paik, Y.-H., Kim, J., Aoyama, T., De Minicis, S., Bataller, R., & Brenner, D. A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5619 · Cited by 219
Liu, J., Chen, S., Wang, W., Ning, B.-F., Chen, F., Shen, W., Ding, J., Chen, W., Xie, W.-F., & Zhang, X. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.022 · Cited by 218
Wilkes, M. C., Mitchell, H., Penheiter, S. G., Doré, J. J., Suzuki, K., Edens, M., Sharma, D. K., Pagano, R. E., & Leof, E. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1522 · Cited by 216
Bornstein, S., White, R., Malkoski, S., Oka, M., Han, G., Cleaver, T., Reh, D., Andersen, P., Gross, N., Olson, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38854 · Cited by 215
Mima, K., Okabe, H., Ishimoto, T., Hayashi, H., Nakagawa, S., Kuroki, H., Watanabe, M., Beppu, T., Tamada, M., Nagano, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0299 · Cited by 215
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis
Mallat, A., & Lotersztajn, S. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2013 · Cited by 211
Valdés, F., Alvarez, A. M., Locascio, A., Vega, S., Herrera, B. M., Fernández, M., Benito, M., Nieto, M. A., & Fabregat, I. (2002) · PubMed · Cited by 211
Self-citationLan, T., Kisseleva, T., & Brenner, D. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129743 · Cited by 209
Wu, K., Ding, J., Chen, C., Sun, W., Ning, B.-F., Wen, W., Huang, L., Han, T., Yang, W., Wang, C., et al. (2012) · Hepatology · doi:10.1002/hep.26007 · Cited by 204
Paik, Y.-H., Iwaisako, K., Seki, E., Inokuchi, S., Schnabl, B., Österreicher, C. H., Kisseleva, T., & Brenner, D. A. (2011) · Hepatology · doi:10.1002/hep.24281 · Cited by 204
Cell plasticity in epithelial homeostasis and tumorigenesis
Varga, J., & Greten, F. R. (2017) · Nature Cell Biology · doi:10.1038/ncb3611 · Cited by 204
Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment
Achyut, B. R., & Yang, L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.048 · Cited by 199
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
Liang, S., Kisseleva, T., & Brenner, D. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00017 · Cited by 197
Emerging Signaling Pathways in Hepatocellular Carcinoma
Moeini, A., Cornellà, H., & Villanueva, A. (2012) · Liver Cancer · doi:10.1159/000342405 · Cited by 195
Cellular Sources of Extracellular Matrix in Hepatic Fibrosis
Wells, R. G. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.008 · Cited by 191
Monocytes and Macrophages as Cellular Targets in Liver Fibrosis
Heymann, F., Trautwein, C., & Tacke, F. (2009) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152809789352230 · Cited by 189
TGF-beta Signaling in Cancer Treatment
Fabregat, I., Fernando, J., Mainez, J., & Sancho, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990591 · Cited by 187
Self-citationNovel roles of Akt and mTOR in suppressing TGF‐β/ALK5‐mediated Smad3 activation
Song, K., Wang, H., Krebs, T. L., & Danielpour, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600917 · Cited by 185
The relevance of the TGF-β Paradox to EMT-MET programs
Morrison, C. D., Parvani, J. G., & Schiemann, W. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.048 · Cited by 183
Liu, Y., Liu, H., Meyer, C., Li, J., Nadalin, S., Königsrainer, A., Weng, H., Dooley, S., & ten Dijke, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478685 · Cited by 181
Imamura, M., Ogawa, T., Sasaguri, Y., Chayama, K., & Ueno, H. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.005 · Cited by 177
Foxm1 transcription factor is required for lung fibrosis and epithelial‐to‐mesenchymal transition
Balli, D., Ustiyan, V., Zhang, Y., Wang, I., Masino, A. J., Ren, X., Whitsett, J. A., Kalinichenko, V. V., & Kalin, T. V. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.336 · Cited by 177
Mazzocca, A., Fransvea, E., Dituri, F., Lupo, L., Antonaci, S., & Giannelli, G. (2010) · Hepatology · doi:10.1002/hep.23285 · Cited by 176
Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
Shirabe, K., Mano, Y., Muto, J., Matono, R., Motomura, T., Toshima, T., Takeishi, K., Uchiyama, H., Yoshizumi, T., Taketomi, A., et al. (2012) · Surgery Today · doi:10.1007/s00595-011-0058-8 · Cited by 174
Cancer-associated fibroblasts in hepatocellular carcinoma
Kubo, N., Araki, K., Kuwano, H., & Shirabe, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6841 · Cited by 173
Hypoxia inducible factors in hepatocellular carcinoma
Chen, C., & Lou, T. (2017) · Oncotarget · doi:10.18632/oncotarget.17358 · Cited by 172
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
Lu, L.-C., Hsu, C.-H., Hsu, C., & Cheng, A.-L. (2016) · Liver Cancer · doi:10.1159/000367754 · Cited by 171
Current management of hepatocellular carcinoma
Tabrizian, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10223 · Cited by 168
Sancho, P., Mainez, J., Crosas-Molist, E., Roncero, C., Fernández-Rodriguez, C. M., Pinedo, F., Huber, H., Eferl, R., Mikulits, W., & Fabregat, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045285 · Cited by 165
Self-citationCopple, B. L. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02205.x · Cited by 164
Fischer, A. N. M., Fuchs, E., Mikula, M., Huber, H., Beug, H., & Mikulits, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210121 · Cited by 162
Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma
Majumdar, A., Curley, S. A., Wu, X., Brown, P., Hwang, J. P., Shetty, K., Yao, Z.-X., He, A. R., Li, S., Katz, L., et al. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.114 · Cited by 161
Role of NADPH oxidases in the redox biology of liver fibrosis
Crosas‐Molist, E., & Fabregat, I. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.005 · Cited by 160
Self-citationJiang, J. X., Mikami, K., Venugopal, S., Li, Y., & Török, N. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.024 · Cited by 158
Ramm, G. A., Nair, V. G., Bridle, K. R., Shepherd, R. W., & Crawford, D. H. G. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65595-2 · Cited by 153
Escaping from the TGF anti-proliferative control
Seoane, J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl068 · Cited by 153
New Insights into the Crossroads between EMT and Stemness in the Context of Cancer
Fabregat, I., Malfettone, A., & Soukupová, J. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030037 · Cited by 152
Self-citationSnail1 suppresses TGF-β-induced apoptosis and is sufficient to trigger EMT in hepatocytes
Franco, D. L., Mainez, J., Vega, S., Sancho, P., Murillo, M. M., de Frutos, C. A., del Castillo, G., López-Blau, C., Fabregat, I., & Nieto, M. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.068692 · Cited by 151
Self-citationAsbestos-Derived Reactive Oxygen Species Activate TGF-Β1
Pociask, D. A., Sime, P. J., & Brody, A. R. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700109 · Cited by 149
Induction of epithelial–mesenchymal transition by transforming growth factor β
Moustakas, A., & Heldin, C. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.002 · Cited by 145
Macrophage Phenotype in Liver Injury and Repair
Sun, Y., Li, X., Meng, X., Huang, C., Zhang, L., & Li, J. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12468 · Cited by 143
Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes
Murillo, M. M., del Castillo, G., Sánchez, A., Fernández, M., & Fabregat, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208664 · Cited by 140
Self-citationFransvea, E., Mazzocca, A., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22731 · Cited by 140
Bitzer, M., Horger, M., Giannini, E. G., Ganten, T. M., Wörns, M., Siveke, J. T., Dollinger, M., Gerken, G., Scheulen, M. E., Wege, H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.043 · Cited by 139
Advances in liver regeneration
Michalopoulos, G. K. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.934358 · Cited by 138
Boudreau, H. E., Emerson, S. U., Korzeniowska, A., Jendrysik, M. A., & Leto, T. L. (2009) · Journal of Virology · doi:10.1128/jvi.01059-09 · Cited by 137
Liver fibrosis: Common mechanisms and antifibrotic therapies
Schuppan, D. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.005 · Cited by 136
Bertrán, E., Crosas‐Molist, E., Sancho, P., Caja, L., López‐Luque, J., Navarro, E., Egea, G., Lastra, R., Serrano, T., Ramos, E., et al. (2013) · Hepatology · doi:10.1002/hep.26597 · Cited by 129
Self-citationEzquerro, I.-J., Lasarte, J. J., Dotor, J., Castilla‐Cortázar, I., Bustos, M., Peñuelas, I., Blanco, G., Rodríguez‐Ortigosa, C. M., Lechuga, M. D. C. G., Greenwel, P., et al. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00101-7 · Cited by 125
Nomura, A., Banerjee, S., Chugh, R., Dudeja, V., Yamamoto, M., Vickers, S. M., & Saluja, A. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3228 · Cited by 121
The role of integrins in TGFβ activation in the tumour stroma
Khan, Z. A., & Marshall, J. F. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2474-y · Cited by 121
Fernando, J., Malfettone, A., Cepeda, E. B., Vilarrasa‐Blasi, R., Bertrán, E., Raimondi, G., Fabra, À., Alvarez, A. M., Fernández‐Salguero, P. M., Fernández‐Rodríguez, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29097 · Cited by 119
Self-citationTGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
Shen, Y., Wei, Y., Wang, Z., Jing, Y., He, H., Yuan, J., Li, R., Zhao, Q., Wei, L., Yang, T., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373976 · Cited by 115
Giannelli, G., Rani, B., Dituri, F., Cao, Y., & Palasciano, G. (2014) · Gut · doi:10.1136/gutjnl-2014-307323 · Cited by 115
Caja, L., Sancho, P., Bertrán, E., Iglesias‐Serret, D., Gil, J., & Fabregat, I. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1482 · Cited by 110
Self-citationFoo, N., Lin, S.-H., Lee, Y., Wu, M., & Wang, Y. (2011) · Toxicology · doi:10.1016/j.tox.2011.01.009 · Cited by 109
Kitisin, K., Ganesan, N., Tang, Y., Jogunoori, W. S., Volpe, E., Kim, S. S., Katuri, V., Kallakury, B., Pishvaian, M. J., Albanese, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210513 · Cited by 109
Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts
Liu, X., Xu, J., Brenner, D. A., & Kisseleva, T. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0018-7 · Cited by 108
Serova, M., Tijeras‐Raballand, A., Santos, C. D., Albuquerque, M., Paradis, V., Neuzillet, C., Benhadji, K. A., Raymond, É., Faivre, S. J., & Gramont, A. D. E. (2015) · Oncotarget · doi:10.18632/oncotarget.4308 · Cited by 107
Murillo, M. M., Carmona‐Cuenca, I., del Castillo, G., Ortiz, C., Roncero, C., Sánchez, A., Fernández, M., & Fabregat, I. (2007) · Biochemical Journal · doi:10.1042/bj20061846 · Cited by 107
Self-citationEpithelial-mesenchymal transitions and hepatocarcinogenesis
Jou, J. H., & Diehl, A. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42615 · Cited by 105
Weng, H., Ciuclan, L. I., Liu, Y., Hamzavi, J., Godoy, P., Gaitantzi, H., Kanzler, S., Heuchel, R. L., Ueberham, U., Gebhardt, R., et al. (2007) · Hepatology · doi:10.1002/hep.21806 · Cited by 102
Caja, L., Bertrán, E., Campbell, J. S., Fausto, N., & Fabregat, I. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22439 · Cited by 101
Self-citationEvidence for and against epithelial-to-mesenchymal transition in the liver
Xie, G., & Diehl, A. M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00289.2013 · Cited by 101
Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis
Luangmonkong, T., Suriguga, S., Bigaeva, E., Boersema, M., Oosterhuis, D., de Jong, K. P., Schuppan, D., Mutsaers, H. A. M., & Olinga, P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13945 · Cited by 98
Dituri, F., Mazzocca, A., Peidrò, F. J., Papappicco, P., Fabregat, I., Santis, F. D., Paradiso, A., Sabbà, C., & Giannelli, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067109 · Cited by 97
Self-citationInhibiting TGF-β signaling in hepatocellular carcinoma
Giannelli, G., Mazzocca, A., Fransvea, E., Lahn, M., & Antonaci, S. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.11.004 · Cited by 90
Malfettone, A., Soukupová, J., Bertrán, E., Crosas‐Molist, E., Lastra, R., Fernando, J., Koudelková, P., Rani, B., Fabra, À., Serrano, T., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.037 · Cited by 88
Self-citationCaja, L., Ortiz, C., Bertrán, E., Murillo, M. M., Miró-Obradors, M. J., Palacios, E., & Fabregat, I. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.09.002 · Cited by 87
Self-citationZhang, H. H., Mei, M.-H., Fei, R., Liu, F., Wang, J. H., Liao, W., Qin, L. L., Wei, L., & Chen, H. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01269.x · Cited by 87
Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
Pinzani, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.001 · Cited by 86 · cited 1×
“After liver insult, non-transformed hepatocytes can undergo EMT as an adaptative response to move and scape from damaged, inflammatory, hypoxic and redox-activated microenvironment allowing them to find better conditions (166).”
BackgroundWijesundera, K. K., Izawa, T., Tennakoon, A. H., Murakami, H., Golbar, H. M., Katou-Ichikawa, C., Tanaka, M., Kuwamura, M., & Yamate, J. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.04.003 · Cited by 86
Carmona‐Cuenca, I., Herrera, B. M., Ventura, J., Roncero, C., Fernández, M., & Fabregat, I. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20568 · Cited by 82
Self-citationTGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis: Updated
Dewidar, B., Soukupová, J., Fabregat, I., & Dooley, S. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0089-8 · Cited by 81
Self-citationdel Castillo, G., Murillo, M. M., Alvarez, A. M., Bertrán, E., Fernández, M., Sánchez, A., & Fabregat, I. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.05.017 · Cited by 79
Self-citationHashimoto, N., Tsunedomi, R., Yoshimura, K., Watanabe, Y., Hazama, S., & Oka, M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-722 · Cited by 78
Fabregat, I., Herrera, B. M., Fernández, M., Alvarez, A. M., Sánchez, A., Roncero, C., Ventura, J., Valverde, Á. M., & Benito, M. (2000) · Hepatology · doi:10.1053/jhep.2000.9774 · Cited by 78
Self-citationDotor, J., López-Vázquez, A. B., Lasarte, J. J., Sarobe, P., García‐Granero, M., Riezu‐Boj, J. I., Martínez, A., Feijoó, E., López‐Sagaseta, J., Hermida, J., et al. (2007) · Cytokine · doi:10.1016/j.cyto.2007.06.004 · Cited by 77
Hepatic Fibrosis and the Microenvironment: Fertile Soil for Hepatocellular Carcinoma Development
Wallace, M. C., & Friedman, S. L. (2014) · Gene Expression · doi:10.3727/105221614x13919976902057 · Cited by 76
The rationale for targeting TGF ‐β in chronic liver diseases
Giannelli, G., Mikulits, W., Dooley, S., Fabregat, I., Moustakas, A., ten Dijke, P., Portincasa, P., Winter, P., Janssen, R. A. J., Leporatti, S., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12596 · Cited by 76
Self-citationBertrán, E., Caja, L., Navarro, E., Sancho, P., Mainez, J., Murillo, M. M., Vinyals, A., Fabra, À., & Fabregat, I. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.06.006 · Cited by 75
Self-citationHepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
Li, H., You, H., Fan, X., & Jia, J. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000079 · Cited by 75
Sancho, P., & Fabregat, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114280 · Cited by 73
Self-citationHepatic Stem Cells: In Search of
Walkup, M. H., & Gerber, D. A. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0063 · Cited by 73
Ding, Z., Jin, G.-N., Liang, H., Wang, W., Chen, W., Datta, P. K., Zhang, M., Zhang, B., & Chen, X. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.027 · Cited by 72
DLPC decreases TGF-β1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells
Cao, Q., Mak, K. M., & Lieber, C. S. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00128.2002 · Cited by 72
Chronic hepatitis C infection–induced liver fibrogenesis is associated with M2 macrophage activation
Bility, M. T., Nio, K., Li, F., McGivern, D. R., Lemon, S. M., Feeney, E. R., Chung, R. T., & Su, L. (2016) · Scientific Reports · doi:10.1038/srep39520 · Cited by 71
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor MicroenvironmentPreprint
Pickup, M. W., Owens, P., & Moses, H. L. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022285 · Cited by 71
Fabregat, I., Sanchez, A., Alvarez, A. M., Nakamura, T., & Benito, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00266-9 · Cited by 70
Self-citationThomas, G. J., Hart, I. R., Speight, P. M., & Marshall, J. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600545 · Cited by 67
Involvement of c-Src kinase in the regulation of TGF-β1-induced apoptosis
Park, S. S., Eom, Y. W., Kim, E. H., Lee, J., Min, D. S., Kim, S., Kim, S., & Choi, K. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207856 · Cited by 67
Proell, V., Carmona‐Cuenca, I., Murillo, M. M., Huber, H., Fabregat, I., & Mikulits, W. (2007) · Comparative Hepatology · doi:10.1186/1476-5926-6-1 · Cited by 67
Self-citationFang, L., Huang, C. Z., Meng, X., Wu, B., Ma, T., Liu, X., Zhu, Q., Zhan, S., & Li, J. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.08.006 · Cited by 67
Sánchez, A., Alvarez, A. M., Benito, M., & Fabregat, I. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650221 · Cited by 61
Self-citationLi, B., Liu, X., Zheng, Q., Kong, M., Zhang, X., Hu, R., Lou, J., Ren, F., Chen, Y., Zheng, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11303-z · Cited by 61
Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy
Llópiz, D., Dotor, J., Casares, N., Bezunartea, J., Díaz‐Valdés, N., Ruiz, M., Aranda, F., Berraondo, P., Prìeto, J., Lasarte, J. J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24656 · Cited by 59
Cited by
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
Liver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307
Cancer nanotechnology: current status and perspectives
Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 266
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
Mohammed, S., Thadathil, N., Selvarani, R., Nicklas, E. H., Wang, D., Miller, B. F., Richardson, A., & Deepa, S. S. (2021) · Aging Cell · doi:10.1111/acel.13512 · Cited by 192
Danger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
Metadata
- Authors
- Fabregat, I., & Caballero-Díaz, D.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2018-09-10
- Volume
- 8
- Pages
- 357-357
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2890778790
- Cited by
- 351
- References
- 226
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.